Advertisement

Pharmaceutical Research

, Volume 11, Issue 11, pp 1657–1662 | Cite as

Transdermal Delivery of Metoprolol by Electroporation

  • Rita Vanbever
  • Nathalie Lecouturier
  • Véronique Préat
Article

Abstract

Electroporation, i.e., the creation of transient “pores” in lipid membranes leading to increased permeability, could be used to promote transdermal drug delivery. We have evaluated metoprolol permeation through full thickness hairless rat skin in vitro following electroporation with an exponentially decaying pulse. Application of electric pulses increased metoprolol permeation as compared to diffusion through untreated skin. Raising the number of twin pulses (300 V, 3 ms; followed after 1 s by 100 V, 620 ms) from 1 to 20 increased drug transport. Single pulse (100 V, 620 ms) was as effective as twin pulse application (2200 V, 1100 V or 300 V, 3 ms; followed after 1 s by 100 V, 620 ms). In order to investigate the effect of pulse voltage on metoprolol permeation, 5 single pulses (each separated by 1 min) were applied at varying voltages from 24 to 450 V (pulse time 620 ms). A linear correlation between pulse voltage and cumulative metoprolol transported after 4 h suggested that voltage controls the quantity of drug delivered. Then, the effect of pulse time on metoprolol permeation was studied by varying pulse duration of 5 single 100 V pulses from 80 to 710 ms (each pulse also separated by 1 min). Cumulative metoprolol transported after 4 h increased linearly with the pulse time. Therefore, pulse time was also a control factor of the quantity of drug delivered but to a lesser extent than the voltage at least at 100 V. The mechanisms behind improved transdermal drug delivery by electroporation involved reversible increased skin permeability, electrophoretic movement of drug into the skin during pulse application, and drug release from the skin reservoir formed by electroporation. Thus, electroporation did occur as shown by the increased transdermal permeation, on indicator of structural skin changes and their reversibility. Electroporation has potential for enhancing transdermal drug delivery.

transdermal drug delivery electroporation metoprolol skin permeation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    J. Hadgraft and R. Guy (Eds). Transdermal Drug Delivery. Developmental Issues and Research Initiatives, Marcel Dekker Inc, 1989Google Scholar
  2. 2.
    R. Guy (Ed) Iontophoresis Adv Drug Delivery Rev. 9:119–317 (1992)Google Scholar
  3. 3.
    D. Chang, B. Chassy, J. Saunders, A. Sowers (Eds). Guide to Electroporation and Electrofusion, Academic Press Inc. 1992.Google Scholar
  4. 4.
    J. Weaver, K. Powell and R. Langer. Transport of molecules across tissue using electroporation. PCT Patent WO 89/06555Google Scholar
  5. 5.
    K. T. Powell, A. W. Morgenthaler and J. Weaver. Tissue elec-troporation-Observation of reversible electrical breakdown in viable frog skin. Biophysical J. 56:1163–1171 (1989)Google Scholar
  6. 6.
    M. Prausnitz, V. Bose, R. Langer and J. Weaver. Transdermal drug delivery by electroporation. Proceed Intern. Symp. Control Rel. Bioact. Mater, 19:232–233 (1992).Google Scholar
  7. 7.
    D. Bommannan, L. Leung, J. Tamada, J. Sharifi, W. Abraham and R. Potts. Transdermal delivery of luteinizing hormone releasing hormone: comparison between electroporation and iontophoresis. Proceed. Intern. Control. Rel. Bioact. Mater. 20:97–98 (1993).Google Scholar
  8. 8.
    M. Prausnitz, V. Bose, C. Lee, J. Pang, R. Langer and J. Weaver, Effects of electroporation conditions on transdermal delivery. Proceed. Intern. Control. Rel. Bioact. Mater. 20:95–96 (1993).Google Scholar
  9. 9.
    M. Prausnitz, V. Bose, R. Langer and J. Weaver, Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc. Natl. Acad. Sci. USA 90:10504–10508 (1993).Google Scholar
  10. 10.
    J. Tamada, J. Sharifi, D. Bommannan, L. Leung, N. Azimi, W. Abraham and R. Potts. Effect of electroporation on the iontophoretic delivery of peptides in vitro. Pharm. Res. 10:S-257 (1993).Google Scholar
  11. 11.
    S. Thysman, V. Préat and M. Roland, Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 81:670–675 (1992)Google Scholar
  12. 12.
    J. Godbillon and M. Duval. Determination of two metoprolol metabolites in human urine by HPLC. J. Chromatogr. 309:198–202 (1984)Google Scholar
  13. 13.
    V. A. Klenchin, S. I. Sukharev, S. M. Serov, L. V. Chernomordik and Y. A. Chizmadzhev. Electrically induced DNA uptake by cells is a fast process involving DNA electrophoresis. Biophys. J. 60:804–811 (1991)Google Scholar
  14. 14.
    V. Préat and S. Thysman. Transdermal iontophoretic delivery of sufentanil, Int. J. Pharm. 96:189–196 (1993)Google Scholar
  15. 15.
    S. Thysman, C. Tasset and V. Préat. Transdermal iontophoresis of fentanyl: delivery and mechanistic analysis. Int. J. Pharm. 101:105–113 (1994)Google Scholar
  16. 16.
    L. M. Mir, S. Orlowski, J. Jr. Belehradek and C. Paoletti. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:68–72 (1991)Google Scholar
  17. 17.
    A. V. Titomirov, S. Sukharev and E. Kistanova. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmic DNA. Biochim. Biophys. Acta 1088:131–134 (1991)Google Scholar
  18. 18.
    M. Belehradek, C. Domenge, B. Luboinski, S. Orlowski, J. Belehradek and L. M. Mir. Electrochemotherapy, a new antitumor treatment: first clinical phase I–II trial. Cancer. 72-12: 3694–3700 (1993)Google Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Rita Vanbever
    • 1
  • Nathalie Lecouturier
    • 1
  • Véronique Préat
    • 1
  1. 1.Université Catholique de Louvain, Unité de Pharmacie GaléniqueBrusselsBelgium

Personalised recommendations